Man in violation of privacy law

Breaking news and expert analysis on legal and compliance issues

[Back To Home][Back To Archives]

From Antitrust Law Daily, August 30, 2017

Mars to divest 12 veterinary clinics to resolve FTC concerns over VCA acquisition

By Jeffrey May, J.D.

In order to receive FTC approval of its proposed $9.1 billion acquisition of pet care company VCA Inc., Mars, Inc. has agreed to divest 12 veterinary clinics around the country. Both parties operate clinics that provide specialty and emergency veterinary services. The divestitures are intended to remedy the loss of head-to-head competition between Mars and VCA in the provision of such services that would have resulted from the merger without the conditions (In re Mars, Inc., FTC File No. 171 0057).

Complaint. According to the FTC complaint, without the divestitures, the transaction, announced in January, would impact certain local markets by: eliminating head-to-head competition between Mars and VCA in the provision of specialty and emergency veterinary services; increasing the likelihood that Mars would unilaterally exercise market power; and increasing the likelihood that customers would be forced to pay higher prices or experience a degradation in quality for the relevant services. The complaint details the potential impact on various veterinary specialties if the divestitures were not required.

Mars is a diversified company with a well-known candy business in addition to a pet care business that includes pet food product manufacturing and the provision of veterinary services. Mars Petcare’s portfolio of veterinary services businesses includes BANFIELD Pet Hospital, BLUEPEARL, and PET PARTNERS.

Proposed FTC consent order. Under the terms of the proposed FTC consent order, Mars has agreed to divest 12 clinics no later than 10 business days after the acquisition is complete. The clinics will be sold to one of three buyers: National Veterinary Associates (NVA), Pathway Partners Vet Management Company, and PetVet Care Centers. Clinics in Kansas City, New York, and Phoenix are to be divested to NVA. Clinics in Portland, Rockville, and Vienna are to be divested to PetVet. Clinics in Chicago, Corpus Christi, San Antonio, and Seattle are to be divested to Pathway, the agency announced. The divestitures will preserve competition between the divested clinics and Mars’ BluePearl or VCA’s clinics, it was noted.

Companies: Mars, Inc.; VCA Inc.

MainStory: TopStory Antitrust AcquisitionsMergers FederalTradeCommissionNews

Back to Top

Antitrust Law Daily

Introducing Wolters Kluwer Antitrust Law Daily — a daily reporting service created by attorneys, for attorneys — providing same-day coverage of breaking news, court decisions, legislation, and regulatory activity.


A complete daily report of the news that affects your world

  • View full summaries of federal and state court decisions.
  • Access full text of legislative and regulatory developments.
  • Customize your daily email by topic and/or jurisdiction.
  • Search archives for stories of interest.

Not just news — the right news

  • Get expert analysis written by subject matter specialists—created by attorneys for attorneys.
  • Track law firms and organizations in the headlines with our new “Who’s in the News” feature.
  • Promote your firm with our new reprint policy.

24/7 access for a 24/7 world

  • Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues.
  • Save time with mobile apps for your BlackBerry, iPhone, iPad, Android, or Kindle.
  • Access all links from any mobile device without being prompted for user name and password.